Medium Article: https://medium.com/@jsmith0475/ai-in-drug-discovery-is-evolving-are-you-ready-for-agentic-ai-1e2adb51a891

Dr. Smith's article discusses the evolution of AI in drug discovery, contrasting traditional, passive AI with the emerging "Agentic AI." This new form of AI actively executes tasks, learns from mistakes, and makes decisions independently, unlike its predecessors which primarily predict and assist. Agentic AI is portrayed as a transformative force capable of accelerating drug development, optimizing clinical trials, and ultimately saving lives. However, the article also considers the ethical implications, emphasizing the need for AI systems with judgment and moral reasoning. The author argues that companies embracing Agentic AI will lead the future of pharmaceuticals, while those who hesitate will be left behind. The article concludes by stating that the shift to Agentic AI is not just a future possibility, but a present reality with profound implications for the industry.